Related Experiment Video
Updated: Jul 17, 2026

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
[Vaccination against pneumococci and hepatitis B in the Dutch National Immunisation Programme]
1Rijksinstituut voor Volksgezondheid en Milieu (RIVM), Centrum Infectieziektebestrijding (CIb), Postbus i, 3720 BA Bilthoven. hein.boot@rivm.nl
Insights
Dutch infants born after March 2006 receive new combination vaccines. This schedule integrates pneumococcal and hepatitis B (HB) protection, aiming for robust, long-lasting immunity in infants, including those at high risk for HB.
Area of Science:
- Pediatric Vaccinology
- Immunology
- Public Health
Context:
- Netherlands national infant immunization program.
- Introduction of a new combination vaccine integrating DTPa-IPV-Hib with Hepatitis B (HB).
- Targeted HB vaccination for infants with parental origin from high-prevalence regions (approx. 15% of newborns).
Purpose:
- To describe the updated vaccination schedule for Dutch infants.
- To evaluate the efficacy of a novel 4-component vaccine (DTPa-IPV-Hib + HB).
- To assess the impact of co-administration with pneumococcal vaccine on HB immune response.
Summary:
- Infants born after March 2006 receive DTPa-IPV-Hib and pneumococcal vaccines at 2, 3, 4, and 11 months.
- High-risk infants receive a combined DTPa-IPV-Hib + HB vaccine 4 times, alongside pneumococcal shots.
- Infants born to HB-infected mothers receive 5 HB vaccinations and serological monitoring for breakthrough infections.
Impact:
- Expected to induce good and long-lasting protection against Hepatitis B in most infants.
- Potential for enhanced insight into the effectiveness of vaccination schemes and interventions against vertical HBV transmission.
- Improved public health outcomes through comprehensive infant immunization against preventable diseases.
Abstract:
All infants in the Netherlands, which are born after March 2006, receive additional vaccinations at the age of 2, 3, 4 and 11 months to protect them against pneumococcal infections. During the same visit to a consultation bureau, the children also receive a combination vaccine against diphtheria, pertussis, tetanus, poliomyelitis and Haemophilus influenzae (DTPa-IPV-Hib). Children of which at least one parent was born in a country where hepatitis B occurs relatively often are also vaccinated in the Netherlands against hepatitis B. This currently pertains to about 15% of all newborns. These children now receive a new combination vaccine in which a hepatitis B component has been added to the DTPa-IPV-Hib components. They will receive this combination vaccine 4 times. This combination vaccine is given during the same visit as the pneumococcal vaccination. Although pneumococcal vaccination may have a somewhat negative effect on the immune response to hepatitis B, it is expected that the new 4-fold vaccination schedule will induce good and long-lasting protection against hepatitis B in the vast majority of the children. About 700 children are born out of mothers infected with hepatitis B each year in the Netherlands. In the new vaccination schedule, they now receive 5 active vaccinations against hepatitis B and are examined serologically on an individual basis in order to detect breakthrough infections. This will also generate greater insight into the efficacy of the different vaccination schemes and intervention programmes to prevent vertical transmission of the virus.
Related Concept Videos
Vaccinations
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Smallpox
Vaccines
Poliomyelitis
Hepatitis

